Wockhardt Foundation and Biogetica have partnered for multidisciplinary research into Covid 19
Biogetica and Wockhardt Foundation have come together to conduct multidisciplinary research into remedies and strategies to effectively combat the Novel Corona Virus. The research to develop the remedy is being conducted under Corival Life Sciences which boasts of a one of its kind partnership between global leaders in the field of Natural & Pharmaceutical Medicines
Corival Life Sciences has conducted reviews of published ‘in vivo’, ‘in vitro’ and ‘in silica’ research on Covid 19 basis which their first product called ‘Immunofree’ was launched. ‘Immunofree’ is now being entered into a pharma control trial along with reginmune, a product made by Biogetica that has already shown ground-breaking results in herpes trials.
The USP of the Corival Life Sciences protocol apart from all others is the fact that it combines evidence based nutraceuticals and potent full spectrum herbal extracts, into easy to use pills that synergistically work in multifaceted ways, during these unprecedented times. This protocol combines learnings from Allopathy, Ayurveda, TCM and Vibrational therapies. It not only boosts immunity but also potentially works on organ protection, docking, inflammation, coagulopathy and bronchodilation. It contains vitamins, minerals, rare amino acids and 18 plants from across the globe that are supported by the latest 2020 research. Furthermore, great care is taken to ensure balance of the 5 elements, so that it can be consumed without upsetting one's constitution. These products are a result of the great ancient sciences and biogetica's various viral and bioavailability patents. ‘Immunofree’ blends a wide variety of phytochemicals, such as alkaloids, polyphenols, flavonoids, saponins, terpenoids, lignans, Xantones, etc. These herbs have specifically been chosen based on research done in 2020. Highly concentrated full spectrum extracts of these herbs are used in Immunofree in doses that cannot be achieved by home remedies.
‘Immunofree’ was designed in 2020 for 2020. The Plants chosen for its constitution include those that potentially dissolve viral envelopes, dock into the virus, boost immunity and protect the organs. Hence ‘Immunofree’ serves as a multifaceted solution to the issues prevalent today. This is a one of kind partnership between pharmaceutical and herbal medicine providers and it has yielded a specific multifaceted formula for this unprecedented time.
Numerous renowned Doctors and Scientists from across the Globe have come together to design ‘Immunofree’, and these include Apruve Mehra PHD, Dr. Vijay Kamat- Medical Director, Biogetica, Scientific team from the Laboratory Equisalud's from Spain, and Dr Vijay Kushvaha, renowned Ayurvedic Physician from Maharashtra.
Valuable inputs for the trial have come in from Dr. Madan Thangavelu from Cambridge who is a Gene Biologist and Dr. Vanita Sharma from Melbourne, Deputy Chair Complementary Health IRC, SkillsIQ Department of Education, Skills and Employment Australia.
Trials are being conducted by renowned global Clinical Trials Firm MGCTS that has prior experience of managing over 100 clinical trials
